4.3 Article

Indications and safety of intravenous and subcutaneous immunoglobulin therapy

Journal

EXPERT REVIEW OF CLINICAL IMMUNOLOGY
Volume 7, Issue 3, Pages 301-316

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1586/ECI.10.104

Keywords

adverse effects; efficacy; immunoglobulin as immunomodulatory therapy; immunogloban as replacement therapy; indication

Categories

Funding

  1. Tehran University of Medical Sciences [89-04-30-12253]
  2. CSL Behring

Ask authors/readers for more resources

Immunoglobulin (Ig) therapy is an important method of treatment for a number of immunological, hematological, neurological and dermatological disorders. Over the years, the range of indications in which Ig therapy, either replacement or immunomodulatory, is effective has substantially increased. Although Ig therapy was originally limited to intramuscular injection, intravenous infusion has became the most frequent route of administration, followed by subcutaneous injection. This article presents current information on indications, mechanisms of action, efficacy and practical aspects of intravenous and subcutaneous Ig replacement/immunomodulatory therapy as well as associated adverse reactions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available